Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

The Management of Lower Urinary Tract Symptoms in Men [Internet].

National Clinical Guideline Centre (UK).

London: Royal College of Physicians (UK); 2010.

2.

WITHDRAWN: Cernilton for benign prostatic hyperplasia.

Wilt TJ, Macdonald R, Ishani A, Rutks I, Stark G.

Cochrane Database Syst Rev. 2011 May 11;(5):CD001042. doi: 10.1002/14651858.CD001042.pub2. Review.

PMID:
21563128
3.

Holmium laser ablation of the prostate versus photoselective vaporization of prostate 60 cc or less: short-term results of a prospective randomized trial.

Elzayat EA, Al-Mandil MS, Khalaf I, Elhilali MM.

J Urol. 2009 Jul;182(1):133-8. doi: 10.1016/j.juro.2009.02.117. Epub 2009 May 17.

PMID:
19447438
4.

Surgical treatments for men with benign prostatic enlargement: cost effectiveness study.

Armstrong N, Vale L, Deverill M, Nabi G, McClinton S, N'Dow J, Pickard R; BPE Study Group.

BMJ. 2009 Apr 16;338:b1288. doi: 10.1136/bmj.b1288.

5.

Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity.

Mavuduru RM, Mandal AK, Singh SK, Acharya N, Agarwal M, Garg S, Kumar S.

Urol Int. 2009;82(2):130-5. doi: 10.1159/000200786. Epub 2009 Mar 19.

PMID:
19321996
6.

Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate.

Autorino R, Damiano R, Di Lorenzo G, Quarto G, Perdonà S, D'Armiento M, De Sio M.

Eur Urol. 2009 Apr;55(4):922-9. doi: 10.1016/j.eururo.2009.01.028. Epub 2009 Jan 24.

PMID:
19185975
7.

Management of large (>60 g) prostate gland: PlasmaKinetic Superpulse (bipolar) versus conventional (monopolar) transurethral resection of the prostate.

Bhansali M, Patankar S, Dobhada S, Khaladkar S.

J Endourol. 2009 Jan;23(1):141-5. doi: 10.1089/end.2007.0005.

PMID:
19178175
8.

Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report.

Liguori G, Trombetta C, De Giorgi G, Pomara G, Maio G, Vecchio D, Ocello G, Ollandini G, Bucci S, Belgrano E.

J Sex Med. 2009 Feb;6(2):544-52. doi: 10.1111/j.1743-6109.2008.01109.x. Epub 2008 Dec 2.

PMID:
19138360
9.

Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report.

Wild D, Eremenco S, Mear I, Martin M, Houchin C, Gawlicki M, Hareendran A, Wiklund I, Chong LY, von Maltzahn R, Cohen L, Molsen E.

Value Health. 2009 Jun;12(4):430-40. doi: 10.1111/j.1524-4733.2008.00471.x. Epub 2008 Nov 12.

10.

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement.

Lourenco T, Armstrong N, N'Dow J, Nabi G, Deverill M, Pickard R, Vale L, MacLennan G, Fraser C, McClinton S, Wong S, Coutts A, Mowatt G, Grant A.

Health Technol Assess. 2008 Nov;12(35):iii, ix-x, 1-146, 169-515. Review.

11.

Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials.

Lourenco T, Pickard R, Vale L, Grant A, Fraser C, MacLennan G, N'Dow J; Benign Prostatic Enlargement team.

BMJ. 2008 Oct 9;337:a1662. doi: 10.1136/bmj.a1662. Review.

12.

Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc.

Skolarikos A, Papachristou C, Athanasiadis G, Chalikopoulos D, Deliveliotis C, Alivizatos G.

J Endourol. 2008 Oct;22(10):2333-40. doi: 10.1089/end.2008.9709.

PMID:
18837655
13.

Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study.

MacDiarmid SA, Peters KM, Chen A, Armstrong RB, Orman C, Aquilina JW, Nitti VW.

Mayo Clin Proc. 2008 Sep;83(9):1002-10. doi: 10.4065/83.9.1002.

PMID:
18775200
14.

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.

Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L.

J Urol. 2008 Oct;180(4):1228-34. doi: 10.1016/j.juro.2008.06.079. Epub 2008 Aug 22.

PMID:
18722631
15.

Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study.

Falahatkar S, Mokhtari G, Pourreza F, Asgari SA, Kamran AN.

Urology. 2008 Oct;72(4):813-6. doi: 10.1016/j.urology.2008.04.069. Epub 2008 Aug 9.

PMID:
18692876
16.

Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.

Kaplan SA, Roehrborn CG, McConnell JD, Meehan AG, Surynawanshi S, Lee JY, Rotonda J, Kusek JW, Nyberg LM Jr; Medical Therapy of Prostatic Symptoms Research Group.

J Urol. 2008 Sep;180(3):1030-2; discussion 1032-3. doi: 10.1016/j.juro.2008.05.004. Epub 2008 Jul 17.

PMID:
18639298
17.

Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.

Rovner ES, Kreder K, Sussman DO, Kaplan SA, Carlsson M, Bavendam T, Guan Z.

J Urol. 2008 Sep;180(3):1034-41. doi: 10.1016/j.juro.2008.05.050. Epub 2008 Jul 17.

PMID:
18639297
18.

Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study.

Bechara A, Romano S, Casabé A, Haime S, Dedola P, Hernández C, Rey H.

J Sex Med. 2008 Sep;5(9):2170-8. doi: 10.1111/j.1743-6109.2008.00940.x. Epub 2008 Jul 14.

PMID:
18638006
19.

Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials.

Lourenco T, Pickard R, Vale L, Grant A, Fraser C, MacLennan G, N'Dow J; Benign Prostatic Enlargement team.

BMJ. 2008 Jun 30;337:a449. doi: 10.1136/bmj.39575.517674.BE. Review.

20.

Absorbent products for urinary/faecal incontinence: a comparative evaluation of key product designs.

Fader M, Cottenden A, Getliffe K, Gage H, Clarke-O'Neill S, Jamieson K, Green N, Williams P, Brooks R, Malone-Lee J.

Health Technol Assess. 2008 Jul;12(29):iii-iv, ix-185. Review.

Supplemental Content

Support Center